Post-acute COVID-19
Clinical trials for Post-acute COVID-19 explained in plain language.
Never miss a new study
Get alerted when new Post-acute COVID-19 trials appear
Sign up with your email to follow new studies for Post-acute COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a drug calm long COVID's lung inflammation? new trial aims to find out
Disease control Recruiting nowThis study tests if the drug anakinra can help people with long COVID who have ongoing breathing issues and signs of an overactive immune system. About 182 adults will receive either anakinra or a placebo for up to 8 weeks. The goal is to see if the drug improves lung function, r…
Matched conditions: POST-ACUTE COVID-19
Phase 2/3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Mindfulness may offer relief for long COVID sufferers
Symptom relief Recruiting nowThis study tests whether a structured mindfulness program can reduce stress, ease Long COVID symptoms, and improve quality of life. Adults with Long COVID will be randomly assigned to start the program right away or after an 8-week wait. All participants continue their usual medi…
Matched conditions: POST-ACUTE COVID-19
Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC